Therapeutics

SB 202026

Tools

Back to the Top

Overview

Name: SB 202026
Synonyms: Memric
Chemical Name: Sabcomeline
Therapy Type: Small Molecule
Target Type: Other Neurotransmitters
Condition(s): Alzheimer's Disease
U.S. FDA Status: Alzheimer's Disease (Discontinued)

Background

SB 202026  is a selective muscarinic M1 receptor partial agonist.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

References

No Available References

Further Reading

No Available Further Reading